MedPage Today11 天
Environmentally Friendlier COPD Inhaler May Also Be More Effective
Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...
Medical Xpress7 天
Study compares single-inhaler triple therapies for treatment of COPD
DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...
Monthly Prescribing Reference4 天
Study Compares Single-Inhaler Triple Therapies for Treatment of COPD
a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched ...
pharmaphorum8 年
Boehringer and Qualcomm collaborate on digital COPD inhaler
is to work with Qualcomm to 'digitally upgrade' its Respimat inhaler, introducing a new connectivity solution to improve medication adherence in chronic obstructive pulmonary disorder (COPD ...
pharmaphorum6 年
AZ boosted by COPD triple inhaler results
AstraZeneca may mount a challenge to GlaxoSmithKline’s three-in-one inhaler for chronic obstructive pulmonary disease (COPD) after a late-stage trial success. AZ’s single inhaler, PT010 ...
News Medical4 天
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPD
They provided evidence to guide treatment decisions for COPD patients. Study: Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease ...